We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Inflammatory Cytokine Levels Predict Patient Outcomes After Traumatic Injury

By LabMedica International staff writers
Posted on 09 Nov 2021
Measurement of the inflammatory cytokines interleukin-6 (IL-6) and interleukin-8 (IL-8) can be used to predict patient outcomes after traumatic injury.

Cytokines are peptides, which are important in cell signaling but cannot cross the lipid bilayer of cells to enter the cytoplasm. More...
Cytokines have been shown to be involved in autocrine, paracrine, and endocrine signaling as immuno-modulating agents. They act through cell surface receptors and are especially important in the immune system where they modulate the balance between humoral and cell-based immune responses and regulate the maturation, growth, and responsiveness of particular cell populations.

Traumatic injury is the leading cause of mortality in patients under the age of 50. It is associated with a complex inflammatory response involving hormonal, immunologic, and metabolic mediators. The marked elevation of cytokines and inflammatory mediators subsequently correlates with the development of post-traumatic complications.

Investigators at the University of Kentucky (Lexington, USA) sought to determine whether elevated cytokine levels provided a predictive value for orthopedic trauma patients. For this study they measured IL-6, IL-8, IL-10, and migration inhibitory factor levels in samples obtained from 58 patients with an average age of 40 years who had experienced severe bone, joint, and muscle trauma. Six of the patients (10%) suffered pulmonary complications and five (9%) had acute kidney injury.

Results revealed that addition of IL-6 levels to baseline models significantly improved prediction of pulmonary complication and hospital length of stay. The addition of IL-8 significantly improved the prediction of acute kidney injury. The addition of post-injury IL-6 level to the baseline New Injury Severity Score (NISS) model was better able to predict the occurrence of pulmonary complications as well as prolonged ICU and hospital length of stay.

“This is the first time we have combined parameters of external anatomic injury (NISS) with parameters of the internal physiologic response to injury (cytokines) to determine trauma patient outcomes,” said first author Dr. Arun Aneja, assistant professor of orthopedics at the University of Kentucky.

The study was published in the November 2, 2021, online edition of the Journal of Orthopaedic Research.

Related Links:
University of Kentucky


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.